Suicidal attempts and increased right amygdala volume in schizophrenia

Schizophrenia Research

Volumn 125, Issue 1, 2011, Pages 30-40

  Spoletini, Ilaria ^a   Piras, Fabrizio ^a   Fagioli, Sabrina ^a   Rubino, Ivo Alex ^b   Martinotti, Giovanni ^c   Siracusano, Alberto ^b   Caltagirone, Carlo ^a,b   Spalletta, Gianfranco ^a  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c CATHOLIC UNIVERSITY   (Italy)

Author keywords

Amygdala; Schizophrenia; Self aggression; Subcortical structures; Suicide; Volumetry

Indexed keywords

ADULT; AGGRESSION; AMYGDALOID NUCLEUS; ARTICLE; BRAIN HYPERTROPHY; CAUDATE NUCLEUS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; GLOBUS PALLIDUS; HIPPOCAMPUS; HUMAN; HYPERTROPHY; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MALE; MODIFIED OVERT AGGRESSION SCALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PUTAMEN; RIGHT HEMISPHERE; SCHIZOPHRENIA; SUICIDE ATTEMPT; THALAMUS;

ADULT; AMYGDALA; ANALYSIS OF VARIANCE; BRAIN MAPPING; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STATISTICS AS TOPIC; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 78650263622     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2010.08.023     Document Type: Article

References (82)

1. Adamec R.E. Evidence that long-lasting potentiation in limbic circuits mediating defensive behaviour in the right hemisphere underlies pharmacological stressor (FG-7142) induced lasting increases in anxiety-like behaviour: role of benzodiazepine receptors. J. Psychopharmacol. 2000, 14(4):307-322.
2. Adamec R.E. Evidence that long-lasting potentiation of amygdala efferents in the right hemisphere underlies pharmacological stressor (FG-7142) induced lasting increases in anxiety-like behaviour: role of GABA tone in initiation of brain and behavioural changes. J. Psychopharmacol. 2000, 14(4):323-339.
3. Adolphs R., Tranel D., Damasio A.R. The human amygdala in social judgment. Nature 1998, 393(6684):470-474.
4. Aguilar E.J., Leal C., Acosta F.J., Cejas M.R., Fernandez L., Gracia R. A psychopathological study of a group of schizophrenic patients after attempting suicide. Are there two different clinical subtypes?. Eur. Psychiatry 2003, 18(4):190-192.
5. Aguilar E.J., Garcia-Marti G., Marti-Bonmati L., Lull J.J., Moratal D., Escarti M.J., Robles M., Gonzalez J.C., Guillamon M.I., Sanjuan J. Left orbitofrontal and superior temporal gyrus structural changes associated to suicidal behavior in patients with schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32(7):1673-1676.
6. Aleman A., Kahn R.S. Strange feelings: do amygdala abnormalities dysregulate the emotional brain in schizophrenia?. Prog. Neurobiol. 2005, 77(5):283-298.
7. Allendoerfer K.L., Shatz C.J. The subplate, a transient neocortical structure: its role in the development of connections between thalamus and cortex. Annu. Rev. Neurosci. 1994, 17:185-218.
8. Altshuler L.L., Bartzokis G., Grieder T., Curran J., Mintz J. Amygdala enlargement in bipolar disorder and hippocampal reduction in schizophrenia: an MRI study demonstrating neuroanatomic specificity. Arch. Gen. Psychiatry 1998, 55(7):663-664.
9. Altshuler L.L., Bartzokis G., Grieder T., Curran J., Jimenez T., Leight K., Wilkins J., Gerner R., Mintz J. An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol. Psychiatry 2000, 48(2):147-162.
10. Ananth H., Popescu I., Critchley H.D., Good C.D., Frackowiak R.S., Dolan R.J. Cortical and subcortical gray matter abnormalities in schizophrenia determined through structural magnetic resonance imaging with optimized volumetric voxel-based morphometry. Am. J. Psychiatry 2002, 159(9):1497-1505.
11. Anisman H., Du L., Palkovits M., Faludi G., Kovacs G.G., Szontagh-Kishazi P., Merali Z., Poulter M.O. Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjects. J. Psychiatry Neurosci. 2008, 33(2):131-141.
12. APA Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Press, Washington, rev. 4th ed.
13. Babalola K.O., Patenaude B., Aljabar P., Schnabel J., Kennedy D., Crum W., Smith S., Cootes T., Jenkinson M., Rueckert D. An evaluation of four automatic methods of segmenting the subcortical structures in the brain. Neuroimage 2009, 47(4):1435-1447.
14. Barkataki I., Kumari V., Das M., Taylor P., Sharma T. Volumetric structural brain abnormalities in men with schizophrenia or antisocial personality disorder. Behav. Brain Res. 2006, 169(2):239-247.
15. Barth P.G. Disorders of neuronal migration. Can. J. Neurol. Sci. 1987, 14(1):1-16.
16. Beautrais A.L., Joyce P.R., Mulder R.T., Fergusson D.M., Deavoll B.J., Nightingale S.K. Prevalence and comorbidity of mental disorders in persons making serious suicide attempts: a case-control study. Am. J. Psychiatry 1996, 153(8):1009-1014.
17. Bernstein H.G., Steiner J., Bogerts B. Glial cells in schizophrenia: pathophysiological significance and possible consequences for therapy. Expert Rev. Neurother. 2009, 9(7):1059-1071.
18. Cahill L. The neurobiology of emotionally influenced memory. Implications for understanding traumatic memory. Ann. NY Acad. Sci. 1997, 821:238-246.
19. Cherubini A., Peran P., Caltagirone C., Sabatini U., Spalletta G. Aging of subcortical nuclei: microstructural, mineralization and atrophy modifications measured in vivo using MRI. Neuroimage 2009, 48(1):29-36.
20. De Bellis M.D., Casey B.J., Dahl R.E., Birmaher B., Williamson D.E., Thomas K.M., Axelson D.A., Frustaci K., Boring A.M., Hall J., Ryan N.D. A pilot study of amygdala volumes in pediatric generalized anxiety disorder. Biol. Psychiatry 2000, 48(1):51-57.
21. Drevets W.C., Price J.L., Bardgett M.E., Reich T., Todd R.D., Raichle M.E. Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacol. Biochem. Behav. 2002, 71(3):431-447.
22. Exner C., Boucsein K., Degner D., Irle E., Weniger G. Impaired emotional learning and reduced amygdala size in schizophrenia: a 3-month follow-up. Schizophr. Res. 2004, 71(2-3):493-503.
23. Fatemi S.H., Earle J.A., McMenomy T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol. Psychiatry 2000, 5(6):654-663. 571.
24. First M.B., Gibbon M., Spitzer R.L., Williams J.B.W., Benjamin L.S. Structured Clinical Interview for DSM-IV Axis II Personality Disorders (SCID-II) 1997, American Psychiatric Press, Washington DC.
25. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
26. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP) 2002, Biometrics Research, New York State Psychiatric Institute, New York.
27. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12(3):189-198.
28. Fornito A., Yucel M., Patti J., Wood S.J., Pantelis C. Mapping grey matter reductions in schizophrenia: an anatomical likelihood estimation analysis of voxel-based morphometry studies. Schizophr. Res. 2009, 108(1-3):104-113.
29. Frazier J.A., Hodge S.M., Breeze J.L., Giuliano A.J., Terry J.E., Moore C.M., Kennedy D.N., Lopez-Larson M.P., Caviness V.S., Seidman L.J., Zablotsky B., Makris N. Diagnostic and sex effects on limbic volumes in early-onset bipolar disorder and schizophrenia. Schizophr. Bull. 2008, 34(1):37-46.
30. Frodl T., Meisenzahl E., Zetzsche T., Bottlender R., Born C., Groll C., Jager M., Leinsinger G., Hahn K., Moller H.J. Enlargement of the amygdala in patients with a first episode of major depression. Biol. Psychiatry 2002, 51(9):708-714.
31. Frodl T., Meisenzahl E.M., Zetzsche T., Born C., Jager M., Groll C., Bottlender R., Leinsinger G., Moller H.J. Larger amygdala volumes in first depressive episode as compared to recurrent major depression and healthy control subjects. Biol. Psychiatry 2003, 53(4):338-344.
32. Giegling I., Olgiati P., Hartmann A.M., Calati R., Moller H.J., Rujescu D., Serretti A. Personality and attempted suicide. Analysis of anger, aggression and impulsivity. J. Psychiatr. Res. 2009, 43(16):1262-1271.
33. Goldney R.D., Wilson D., Dal Grande E., Fisher L.J., McFarlane A.C. Suicidal ideation in a random community sample: attributable risk due to depression and psychosocial and traumatic events. Aust N Z J Psychiatry 2000, 34(1):98-106.
34. Gur R.E., Kohler C., Turetsky B.I., Siegel S.J., Kanes S.J., Bilker W.B., Brennan A.R., Gur R.C. A sexually dimorphic ratio of orbitofrontal to amygdala volume is altered in schizophrenia. Biol. Psychiatry 2004, 55(5):512-517.
35. Harris E.C., Barraclough B. Excess mortality of mental disorder. Br. J. Psychiatry 1998, 173:11-53.
36. Hawton K., Sutton L., Haw C., Sinclair J., Deeks J.J. Schizophrenia and suicide: systematic review of risk factors. Br. J. Psychiatry 2005, 187:9-20.
37. Health N. In harm's way: suicide in America 1998, National Institute of Mental Health, Bethesda, MD.
38. Heila H., Isometsa E.T., Henriksson M.M., Heikkinen M.E., Marttunen M.J., Lonnqvist J.K. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am. J. Psychiatry 1997, 154(9):1235-1242.
39. Honea R., Crow T.J., Passingham D., Mackay C.E. Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am. J. Psychiatry 2005, 162(12):2233-2245.
40. Hong C.J., Pan G.M., Tsai S.J. Association study of onset age, attempted suicide, aggressive behavior, and schizophrenia with a serotonin 1B receptor (A-161T) genetic polymorphism. Neuropsychobiology 2004, 49(1):1-4.
41. Hoptman M.J., Volavka J., Johnson G., Weiss E., Bilder R.M., Lim K.O. Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study. Biol. Psychiatry 2002, 52(1):9-14.
42. Hoptman M.J., Ardekani B.A., Butler P.D., Nierenberg J., Javitt D.C., Lim K.O. DTI and impulsivity in schizophrenia: a first voxelwise correlational analysis. NeuroReport 2004, 15(16):2467-2470.
43. Hoptman M.J., Volavka J., Weiss E.M., Czobor P., Szeszko P.R., Gerig G., Chakos M., Blocher J., Citrome L.L., Lindenmayer J.P., Sheitman B., Lieberman J.A., Bilder R.M. Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder. Psychiatry Res. 2005, 140(2):133-145.
44. Hoptman M.J., Volavka J., Czobor P., Gerig G., Chakos M., Blocher J., Citrome L.L., Sheitman B., Lindenmayer J.P., Lieberman J.A., Bilder R.M. Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder. J. Neuropsychiatry Clin. Neurosci. 2006, 18(4):509-515.
45. Hoptman M.J., D'Angelo D., Catalano D., Mauro C.J., Shehzad Z.E., Kelly A.M., Castellanos F.X., Javitt D.C., Milham M.P. Amygdalofrontal functional disconnectivity and aggression in schizophrenia. Schizophr. Bull. 2009, 10.1093/schbul/sbp012.
46. Jones P., Rodgers B., Murray R., Marmot M. Child development risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994, 344(8934):1398-1402.
47. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13(2):261-276.
48. Kay S.R., Wolkenfeld F., Murrill L.M. Profiles of aggression among psychiatric patients. I. Nature and prevalence. J. Nerv. Ment. Dis. 1988, 176(9):539-546.
49. Kluver H., Bucy P. Preliminary analysis of functions of the temporal lobe in monkeys. Arch. Neurol. Psychiatry 1939, 42:979-1000.
50. LeDoux J.E. Emotion circuits in the brain. Annu. Rev. Neurosci. 2000, 23:155-184.
51. Lui S.Y. Risk factors for deliberate self-harm and completed suicide in young Chinese people with schizophrenia. Aust N Z J Psychiatry 2009, 43(3):252-259.
52. Mann J.J. Neurobiology of suicidal behaviour. Nat. Rev. Neurosci. 2003, 4(10):819-828.
53. Mann J.J. What does brain imaging tell us about the predisposition to suicidal behavior. Crisis 2005, 26(3):101-103.
54. Marin-Padilla M. Developmental neuropathology and impact of perinatal brain damage. III: gray matter lesions of the neocortex. J. Neuropathol. Exp. Neurol. 1999, 58(5):407-429.
55. McDonald A.J. Cortical pathways to the mammalian amygdala. Prog. Neurobiol. 1998, 55(3):257-332.
56. Measso G., Cavarzeran F., Zappala G., Lebowitz B.D., Crook T.H., Pirozzolo F.J., Amaducci L.A., Massari D., Grigoletto F. The Mini- Mental State Examination: normative study of an Italian random sample. Dev. Neuropsychol. 1993, 9:77-85.
57. Mega M.S., Cummings J.L. Frontal-subcortical circuits and neuropsychiatric disorders. J. Neuropsychiatry Clin. Neurosci. 1994, 6(4):358-370.
58. Mitchell R.L., Crow T.J. Right hemisphere language functions and schizophrenia: the forgotten hemisphere?. Brain 2005, 128(Pt 5):963-978.
59. Monkul E.S., Hatch J.P., Nicoletti M.A., Spence S., Brambilla P., Lacerda A.L., Sassi R.B., Mallinger A.G., Keshavan M.S., Soares J.C. Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol. Psychiatry 2007, 12(4):360-366.
60. Montross L.P., Zisook S., Kasckow J. Suicide among patients with schizophrenia: a consideration of risk and protective factors. Ann. Clin. Psychiatry 2005, 17(3):173-182.
61. Morey R.A., Petty C.M., Xu Y., Hayes J.P., Wagner H.R., Lewis D.V., LaBar K.S., Styner M., McCarthy G. A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes. Neuroimage 2009, 45(3):855-866.
62. Naudts K., Hodgins S. Neurobiological correlates of violent behavior among persons with schizophrenia. Schizophr. Bull. 2006, 32(3):562-572.
63. Oquendo M.A., Baca-Garcia E., Kartachov A., Khait V., Campbell C.E., Richards M., Sackeim H.A., Prudic J., Mann J.J. A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression. J. Clin. Psychiatry 2003, 64(7):825-833.
64. Patenaude B., Smith S., Kennedy D., Jenkinson M. FIRST - FMRIB's Integrated Registration and Segmentation Tool. Thirteenth Annual Meeting of the Organization for Human Brain Mapping - HBM 2007, June 10-14 Chicago, IL, USA.
65. Pompili M., Amador X.F., Girardi P., Harkavy-Friedman J., Harrow M., Kaplan K., Krausz M., Lester D., Meltzer H.Y., Modestin J., Montross L.P., Mortensen P.B., Munk-Jorgensen P., Nielsen J., Nordentoft M., Saarinen P.I., Zisook S., Wilson S.T., Tatarelli R. Suicide risk in schizophrenia: learning from the past to change the future. Ann. Gen. Psychiatry 2007, 6:10.
66. Rusch N., Spoletini I., Wilke M., Martinotti G., Bria P., Trequattrini A., Bonaviri G., Caltagirone C., Spalletta G. Inferior frontal white matter volume and suicidality in schizophrenia. Psychiatry Res. 2008, 164(3):206-214.
67. Siever L.J. Neurobiology of aggression and violence. Am. J. Psychiatry 2008, 165(4):429-442.
68. Soyka M. Aggression in schizophrenia: assessment and prevalence. Br. J. Psychiatry 2002, 180:278-279.
69. Spalletta G., Troisi A., Alimenti S., di Michele F., Pau F., Pasini A., Caltagirone C. Reduced prefrontal cognitive activation associated with aggression in schizophrenia. Schizophr. Res. 2001, 50(1-2):134-135.
70. Spoletini I., Cherubini A., Banfi G., Rubino I.A., Peran P., Caltagirone C., Spalletta G. Hippocampi, thalami, and accumbens microstructural damage in schizophrenia: a volumetry, diffusivity, and neuropsychological study. Schizophr. Bull. 2009, 10.1093/schbul/sbp058.
71. Steiner J., Bielau H., Brisch R., Danos P., Ullrich O., Mawrin C., Bernstein H.G., Bogerts B. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J. Psychiatr. Res. 2008, 42(2):151-157.
72. Swanson J.W., Swartz M.S., Borum R., Hiday V.A., Wagner H.R., Burns B.J. Involuntary out-patient commitment and reduction of violent behaviour in persons with severe mental illness. Br. J. Psychiatry 2000, 176:324-331.
73. Tebartz van Elst L., Woermann F.G., Lemieux L., Trimble M.R. Amygdala enlargement in dysthymia-a volumetric study of patients with temporal lobe epilepsy. Biol. Psychiatry 1999, 46(12):1614-1623.
74. Tebartz Van Elst L., Baeumer D., Lemieux L., Woermann F.G., Koepp M., Krishnamoorthy S., Thompson P.J., Ebert D., Trimble M.R. Amygdala pathology in psychosis of epilepsy: a magnetic resonance imaging study in patients with temporal lobe epilepsy. Brain 2002, 125(Pt 1):140-149.
75. Tebartz van Elst L., Ebert D., Hesslinger B. Amygdala volume status might reflect dominant mode of emotional information processing. Arch. Gen. Psychiatry 2007, 64(2):251-252. author reply 252-253.
76. Turecki G. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J. Psychiatry Neurosci. 2005, 30(6):398-408.
77. van Rijn S., Aleman A., Swaab H., Kahn R.S. Neurobiology of emotion and high risk for schizophrenia: role of the amygdala and the X-chromosome. Neurosci. Biobehav. Rev. 2005, 29(3):385-397.
78. Velakoulis D., Wood S.J., Wong M.T., McGorry P.D., Yung A., Phillips L., Smith D., Brewer W., Proffitt T., Desmond P., Pantelis C. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals. Arch. Gen. Psychiatry 2006, 63(2):139-149.
79. Vogels O.J., Broere C.A., Nieuwenhuys R. Neuronal hypertrophy in the human supraoptic and paraventricular nucleus in aging and Alzheimer's disease. Neurosci. Lett. 1990, 109(1-2):62-67.
80. Vyas A., Mitra R., Shankaranarayana Rao B.S., Chattarji S. Chronic stress induces contrasting patterns of dendritic remodeling in hippocampal and amygdaloid neurons. J. Neurosci. 2002, 22(15):6810-6818.
81. Wong T.H., Lumsden J., Fenton G.W., Fenwick P.B. Neuroimaging in mentally abnormal offenders. Issues of Criminology and Legal Psychology. 1997, 27:49-58.
82. Young L.T., Bezchlibnyk Y.B., Chen B., Wang J.F., MacQueen G.M. Amygdala cyclic adenosine monophosphate response element binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment. Biol. Psychiatry 2004, 55(6):570-577.